Hutch News

Hutch News

Stories tagged 'immunotherapy'

Good News at Fred Hutch

Celebrating faculty and staff achievements

Sept. 14, 2017

An immunotherapy technology developed by Dr. Brian Till with Dr. Oliver Press at Fred Hutchinson Cancer Research Center has been licensed by Mustang Bio Inc., a subsidiary of the biopharmaceutical company Fortress Biotech Inc. The exclusive, worldwide license, announced Sept. 14 by Mustang Bio, will allow a new type of CAR (chimeric antigen receptor) T-cell therapy to be tested in a clinical trial as a treatment for B-cell non-Hodgkin lymphomas. The novel immunotherapy targets CD20, a protein marker on cancer cells in lymphoma.

View story >


Teacher, mom — and living proof of principle

Three years ago she was out of options to treat her advanced cancer. Then, she enrolled in an immunotherapy clinical trial.

Sept. 8, 2017 | By Susan Keown / Fred Hutch News Service

When Tiffany's advanced cancer kept coming back, she decided to become the first person in the world to receive a still-experimental new immunotherapy.

View story >


New nanoparticles make targeted, temporary gene therapy possible

‘Hit-and-run’ technology could improve immunotherapy and HIV cure research

Aug. 30, 2017 | By Sabrina Richards / Fred Hutch News Service

'Hit-and-run' technology could improve immunotherapy and HIV cure research

View story >


Looking for ‘a multitude of ways to cure HIV’

HIV researchers draw hope from cancer immunotherapies — and inspiration from Timothy Ray Brown

Aug. 21, 2017 | By Mary Engel / Fred Hutch News Service

HIV researchers draw hope from advances in cancer immunotherapies — and inspiration from Timothy Ray Brown's now 10-year-old cure.

View story >


Dr. Carl June weaves together HIV and cancer research to advance cures for both

CAR T-cell pioneer and one-time bone marrow transplant fellow will give keynote at HIV cure conference

Aug. 17, 2017 | By Mary Engel / Fred Hutch News Service

Being in two camps — HIV and cancer research — at one time "made a huge, huge impact on me," says immunotherapy researcher Dr. Carl June.

View story >


New integrated research center launches

Dr. Denise Galloway heads new collaborative center to study prevention and treatment of cancers linked to infectious agents

Aug. 10, 2017 | By Sabrina Richards / Fred Hutch News Service

Dr. Denise Galloway heads new collaborative center to research prevention and treatment of infection-related cancers

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.